peptides3 min readApril 9, 2026

AOD-9604 + Fragment 176-191 Fat Loss Stack: A Synergistic Approach

For individuals seeking to optimize their fat loss efforts, combining AOD-9604 and Fragment 176-191 can offer a synergistic approach.

AOD-9604 and Fragment 176-191 vials

For individuals seeking to optimize their fat loss efforts, combining AOD-9604 and Fragment 176-191 can offer a synergistic approach. Both peptides are derived from human growth hormone (HGH) and share similar fat-burning properties, but they also have unique characteristics that make them a powerful combination.

Understanding the Synergy

AOD-9604, as previously discussed, is a modified fragment of HGH that stimulates lipolysis and inhibits lipogenesis. Fragment 176-191, on the other hand, is the pure, unmodified C-terminal fragment of HGH. While both peptides target fat cells, they do so through slightly different pathways, which can lead to a more comprehensive and effective fat loss experience.

Fragment 176-191 is known for its potent lipolytic effects, but it has a shorter half-life than AOD-9604. By stacking the two peptides, you can benefit from the rapid onset of Fragment 176-191 and the sustained effects of AOD-9604. This combination can lead to a more consistent and prolonged state of fat burning.

The AOD-9604 + Fragment 176-191 Stack Protocol

This protocol is designed for experienced peptide users who are looking to take their fat loss to the next level. It is important to start with a lower dose and gradually increase it as tolerated.

Dosage and Administration

The recommended dosage for this stack is 300mcg of AOD-9604 and 300mcg of Fragment 176-191 per day. The two peptides can be administered in the same syringe or in separate injections. It is best to take the stack in the morning on an empty stomach to maximize its fat-burning effects.

PeptideDaily DosageAdministration
AOD-9604300mcgSubcutaneous injection
Fragment 176-191300mcgSubcutaneous injection

Cycle Length

A typical cycle for this stack is 8-12 weeks. After the cycle, it is important to take a break of at least 4 weeks to allow the body to recover and prevent desensitization to the peptides.

Potential Benefits of the Stack

  • Enhanced Fat Loss: The synergistic effects of the two peptides can lead to more significant and rapid fat loss.
  • Improved Body Composition: The stack can help to preserve lean muscle mass while promoting fat loss, leading to a more toned and defined physique.
  • Increased Energy Levels: Many users report an increase in energy levels and improved workout performance while on this stack.
  • Targeted Fat Reduction: The stack is particularly effective at targeting stubborn fat deposits, such as abdominal fat.

Key Takeaways

  • AOD-9604 and Fragment 176-191 are both potent fat-burning peptides.
  • Stacking the two peptides can lead to a synergistic effect and enhanced fat loss.
  • The recommended dosage is 300mcg of each peptide per day.
  • A typical cycle is 8-12 weeks, followed by a 4-week break.
  • The stack can help to improve body composition, increase energy levels, and target stubborn fat.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting any peptide therapy or making changes to your health regimen.

Citations

  1. Ng, F. M., et al. "Investigation of a synthetic human growth hormone fragment (AOD9604) on lipid metabolism in genetically obese rodents." Journal of peptide research 58.3 (2001): 259-268. https://pubmed.ncbi.nlm.nih.gov/11713213/
  2. Heffernan, M., et al. "The effects of human growth hormone and its lipolytic fragment (AOD9604) on lipid metabolism and insulin sensitivity in obese Zucker rats." International journal of obesity 25.10 (2001): 1442-1449. https://pubmed.ncbi.nlm.nih.gov/11673763/
  3. Stier, H., et al. "Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans." Journal of Endocrinology and Metabolism 1.1 (2013): 1-6. https://www.jofem.org/index.php/jofem/article/view/213/278
aod-9604fragment 176-191fat lossweight losspeptides
Share this article:

Dr. Sarah Chen, PharmD, BCPS

Verified Reviewer

Board-Certified Pharmacotherapy Specialist

Dr. Sarah Chen is a board-certified pharmacotherapy specialist with expertise in peptide pharmacokinetics, GLP-1 receptor agonist therapy, and drug interaction analysis. She has published research on ...

Clinical PharmacologyGLP-1 AgonistsDrug InteractionsView full profile
To keep OnlinePeptideDoctor.com free, please support our sponsors
Personalized Protocols

Want a personalized protocol based on your bloodwork, goals, and biology?

Work with licensed providers who specialize in peptide therapy and hormone optimization.

This article is for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any peptide, hormone, or TRT protocol. Individual results may vary.

Related Articles

Related Searches on OnlinePeptideDoctor.com

Compare Testosterone Cream vs Testosterone Injections: mechanisms of action, clinical evidence, dosing protocols, side effects, cost, and which is better for different goals

Testosterone cream and injections are both effective TRT methods. Cream offers steady absorption through the skin, while injections provide higher, more immediate testosterone levels. The best choice depends on individual needs, lifestyle, side effect profile, and treatment goals, considering factors like convenience, cost, and desired testosterone fluctuations.

Search result

BPC-157 vs TB-500 for injury recovery

BPC-157 and TB-500 are both peptides studied for injury recovery, but they function differently. BPC-157, derived from gastric juice, promotes tissue repair and angiogenesis. TB-500, a synthetic version of Thymosin Beta-4, enhances cell migration and reduces inflammation, making them complementary for diverse healing needs.

Search result

Compare Semaglutide vs Tirzepatide: mechanisms of action, clinical evidence, dosing protocols, side effects, cost, and which is better for different goals

Semaglutide and Tirzepatide are incretin-based therapies for type 2 diabetes and weight loss. Semaglutide is a GLP-1 receptor agonist, while Tirzepatide is a dual GLP-1 and GIP receptor agonist, offering potentially greater efficacy due to its dual action. Both regulate blood sugar and reduce appetite.

Search result

Compare AOD-9604 vs Semaglutide: mechanisms of action, clinical evidence, dosing protocols, side effects, cost, and which is better for different goals

AOD-9604 is a synthetic peptide that stimulates fat metabolism without affecting appetite or blood sugar, while Semaglutide is a GLP-1 receptor agonist that regulates appetite, slows gastric emptying, and improves insulin sensitivity. Semaglutide has extensive clinical evidence for weight loss and diabetes, whereas AOD-9604's evidence is more limited.

Search result
Support our sponsors to keep OnlinePeptideDoctor.com free

Want a personalized protocol based on your goals and bloodwork?